According to the analysis of Reports and Data, the global acute respiratory distress syndrome market was valued at USD 583.8 Million in 2018 and is expected to reach USD 934.8 Million by the year 2027, at a CAGR of 6.0%.
According to the analysis of Reports and Data, the global acute respiratory distress syndrome market was valued at USD 583.8 Million in 2018 and is expected to reach USD 934.8 Million by the year 2027, at a CAGR of 6.0%. Acute respiratory distress syndrome (ARDS) is a type of respiratory failure, which is a form of lung inflammation. Due to which there is a problem with the proper delivery of the oxygen to the different body organs, which at the end impact the appropriate functioning of the parts. Various causes are included with the ARDS, such as sepsis, trauma, pneumonia, and others. The primary treatment for the ARDS involves mechanical ventilation, which is delivered through a rigid tube that enters the oral cavity and is secured in the airway.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/2089
According to a survey done by the World Health Organization (WHO), it is seen that more than 3 million people are effects due to acute respiratory distress syndrome. It can affect people of all ages. The main reason for the ARDS is air pollution, which is caused due to the emission by the vehicles. The harmful gases emitted are inhaled by the people thus leading to several problems.
Different strategic initiatives have been undertaken by the various players in the ARDS industry. For instance, on December 2018, Windtree Therapeutics, Inc. a biopharmaceutical company merged with CVie Therapeutics and launched AEROSURF, a combination drug/device product which is used to treat respiratory distress syndrome.
The Asia Pacific region is the highest-growing region from a geographical perspective in the acute respiratory distress syndrome market. Thus, the advancement in the healthcare sector is expected to propel the market growth. China, India, and Japan are driving the growth of the acute respiratory distress syndrome market in the Asia-pacific region with growth in the lung injury and brain damage due to the rise in the car accidents in this region.
Further key findings from the report suggest
-
- The market for acute respiratory distress syndrome is anticipated to grow at a CAGR of 8.3% in the Asia-Pacific, followed by North America and Europe, with 4.8% and 5.7% CAGR, respectively. Increasing chronic diseases and the rise in air pollution are the key factors to accelerate market growth during the forecast period across all regions.
- As of 2018, the therapeutic device segment was valued at USD 291.9 Million and is expected to grow at a CAGR of 5.8% during the forecast period. Increasing preference for gastrointestinal bleeding and pulmonary fibrosis has been one of the reasons for the growth of the acute respiratory distress syndrome market.
- Due to the ARDS, various complications related to the brain and lung are noticed. Neurological hypoxic brain damage is also one of the injury types, which is reported for acute respiratory distress syndrome.
- The treatment of acute respiratory distress syndrome is Fibro Proliferate, resolution stage, recovery stage, and many more.
- The Asia-Pacific is the largest region for the acute respiratory distress syndrome market due to the significant contribution from countries like China, Japan, India, and Korea due to the growing end-segment and sales channel industries.
- Asia Pacific region is accounted for the third largest market share in 2017, due to consumption in well establishes and end-user segment industries.
- Among the region, North America has the largest market share. The primary driver for the acute respiratory distress syndrome market in North America is the growing brain injury, thus owing to the increase in injury type segment for the ARDS market.
The ongoing pandemic is significantly changing the dynamics of the pharma and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, healthcare devices in hospitals. This is expected to open lucrative growth opportunities for market players in the coming years.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
Faron Pharmaceuticals, BioMarck Pharmaceuticals, GE Healthcare, Hamilton Medical AG, Smiths Medical, Athersys, GlaxoSmithKline, Altor Bioscience, and Mondobiotech.
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/acute-respiratory-distress-syndrome-ards-market
Acute Respiratory Distress Syndrome (ARDS) Market Segmentation:
Device Type (Revenue in USD Million; Volume in Tons, 2016–2027)
- Monitoring Devices
- Diagnostic Devices
- Blood Gas Analyzers
- Pulse Oximeters
- Spirometers
- Capnography Devices
- Other Diagnostic Devices
- Therapeutic Devices
- Mechanical Ventilators
- Invasive And Non-invasive Ventilators
- Drug Delivery Devices
- Nebulizers
- Humidifiers
- PAP
- Other Therapeutic Devices
- Mechanical Ventilators
Injury Type (Revenue in USD Million; Volume in Tons, 2016–2027)
- Brain Injury
- Lung Injury
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/2089
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data:
Point of Care Molecular Diagnostics Market Analysis, By Product And Services (Assay Kits, Software, And Services), By Technology (PCR, IN-Situ Hybridization), By Application (Oncology), By End Use (Decentralized Labs, Hospitals), And Forecasts To 2028 Download PDF Brochure
Syringes and Needles Market Size, Share And Industry Analysis By Product Type (Blood Collection, Drug Delivery, Biopsy, Dental, Ophthalmic, Catheter, Epidural, Anesthesia, Others), By Material Type, By Application, By End Use And By Region Forecast To 2028 Download PDF Brochure
Spina Bifida Market Size, Share And Industry Analysis By Disease Type (Myelomeningocele, Occulta, Closed neural tube defects, Meningocele), By Treatment (Medical procedures, Surgeries, Oral Medications, Others), By Diagnosis (Ultrasound, Blood tests, Amniocentesis, Others), By End-user (Hospital, Clinics, Diagnostic centers, Pharmacies, Others) And Region, Segment Forecasts To 2027 Download PDF Brochure
Infusion Therapy Market By Disease Type, By Therapy Type, By Product Type And By End-Use (Hospitals, Clinics, Ambulatory Surgery Centers, Home Care, Others), Forecasts To 2027 Download PDF Brochure
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs